Outlook Therapeutics Inc. (NASDAQ: OTLK)
$2.1900
+0.0100 ( +0.46% ) 1.0K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$2.1900
Previous close
$2.1800
Volume
1.0K
Market cap
$54.29M
Day range
$2.1800 - $2.1900
52 week range
$0.8700 - $12.8499
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Mar 08, 2024 |
| 4 | Insider transactions | 1 | Mar 08, 2024 |
| 4 | Insider transactions | 1 | Mar 08, 2024 |
| 4 | Insider transactions | 1 | Mar 08, 2024 |
| 8-k | 8K-related | 15 | Mar 07, 2024 |
| 8-k | 8K-related | 16 | Feb 14, 2024 |
| 10-q | Quarterly Reports | 70 | Feb 14, 2024 |
| ars | Annual reports | 1 | Feb 08, 2024 |
| def | Proxies and info statements | 6 | Feb 08, 2024 |
| pre | Proxies and info statements | 6 | Jan 29, 2024 |